More CREDENCE for SGLT2 Inhibition

被引：14
|
作者：
Verma, Subodh [1 ]
Bhatt, Deepak L. [2 ]
机构：
[1] Univ Toronto, St Michaels Hosp, Div Cardiac Surg, 8th Floor,Bond Wing,30 Bond St, Toronto, ON M5B 1W8, Canada
[2] Harvard Med Sch, Brigham & Womens Hosp, Heart & Vasc Ctr, Boston, MA 02115 USA
来源：
CIRCULATION | 2019年 / 140卷 / 18期
关键词：
cardiovascular diseases; diabetes mellitus; diabetic nephropathies; kidney failure; chronic;
D O I：
10.1161/CIRCULATIONAHA.119.041181
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1448 / 1450
页数：3
相关论文
共 50 条
  • [1] Nephroprotection via SGLT2 inhibition
    Wanner, C.
    DIABETOLOGE, 2018, 14 (02): : 93 - 95
  • [2] Nephroprotektion durch SGLT-2-HemmungNephroprotection via SGLT2 inhibition
    C. Wanner
    Der Diabetologe, 2018, 14 : 93 - 95
  • [3] Metabolic Communication by SGLT2 Inhibition
    Billing, Anja M.
    Kim, Young Chul
    Gullaksen, Soren
    Schrage, Benedikt
    Raabe, Janice
    Hutzfeldt, Arvid
    Demir, Fatih
    Kovalenko, Elina
    Lasse, Moritz
    Dugourd, Aurelien
    Fallegger, Robin
    Klampe, Birgit
    Jaegers, Johannes
    Li, Qing
    Kravtsova, Olha
    Crespo-Masip, Maria
    Palermo, Amelia
    Fenton, Robert A.
    Hoxha, Elion
    Blankenberg, Stefan
    Kirchhof, Paulus
    Huber, Tobias B.
    Laugesen, Esben
    Zeller, Tanja
    Chrysopoulou, Maria
    Saez-Rodriguez, Julio
    Magnussen, Christina
    Eschenhagen, Thomas
    Staruschenko, Alexander
    Siuzdak, Gary
    Poulsen, Per L.
    Schwab, Clarissa
    Cuello, Friederike
    Vallon, Volker
    Rinschen, Markus M.
    CIRCULATION, 2024, 149 (11) : 860 - 884
  • [4] SGLT2 inhibition and glucagon secretion in humans
    Saponaro, C.
    Pattou, F.
    Bonner, C.
    DIABETES & METABOLISM, 2018, 44 (05) : 383 - 385
  • [5] Does SGLT1 Inhibition Add Benefit to SGLT2 Inhibition in Type 2 Diabetes?
    Pitt, Bertram
    Bhatt, Deepak L.
    CIRCULATION, 2021, 144 (01) : 4 - 6
  • [6] SGLT2 inhibition and heart failure—current concepts
    Joaquim Silva Custodio
    Andre Rodrigues Duraes
    Marconi Abreu
    Natalia Albuquerque Rocha
    Leonardo Roever
    Heart Failure Reviews, 2018, 23 : 409 - 418
  • [7] SGLT2 Inhibition Changing What Fuels the Heart
    Lehrke, Michael
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (15) : 1945 - 1947
  • [8] Kidney and cardiovascular protection with SGLT2 inhibitors: lessons from cardiovascular outcome trials and CREDENCE
    O'Hara, D. V.
    Neuen, B. L.
    Jardine, M. J.
    JOURNAL OF NEPHROLOGY, 2020, 33 (05) : 977 - 983
  • [9] Renal, metabolic and cardiovascular considerations of SGLT2 inhibition
    DeFronzo, Ralph A.
    Norton, Luke
    Abdul-Ghani, Muhammad
    NATURE REVIEWS NEPHROLOGY, 2017, 13 (01) : 11 - 26
  • [10] Sodium Glucose Transport 2 (SGLT2) Inhibition Decreases Glomerular Hyperfiltration Is There a Role for SGLT2 Inhibitors in Diabetic Kidney Disease?
    Stanton, Robert C.
    CIRCULATION, 2014, 129 (05) : 542 - 544
12345